Nishigandha Phalke's Contact Details

Nishigandha Phalke's Company Details

Massachusetts' first and only public academic health sciences center is made up of three graduate schools and two business divisions, Commonwealth Medicine and MassBiologics. Perennially ranked among the top medical schools for primary care education by U.S. News & World Report, UMass Chan Medical School is also an international leader in biomedical research, with $399 million in NIH funding in FY 2020. UMass Chan Medical School educates physicians, scientists and advanced practice nurses to heal, discover, teach and care with compassion. Our researchers are making discoveries daily in the fight against diseases such as ALS, Tay-Sachs, COVID-19, cancer and diabetes. UMass Medical School strives to advance the health and well-being of the people of the commonwealth and the world through pioneering education, research and health care delivery with clinical partner UMass Memorial Health. Commonwealth Medicine provides a wide range of care management and consulting services to government agencies, nonprofits and health care organizations, improving health care for people in need while also maximizing revenue for clients and performing cutting edge research that impacts health policy. MassBiologics, the only nonprofit, FDA-licensed manufacturer of vaccines and biologics in the United States, improves public health through applied research, development and production of biologic products, including vaccines, plasma derivatives and monoclonal antibodies.